Want to come to our 2025 event but need to convince your manager?
Here are 5 reasons to use to convince them:
1.
15+ hours of dedicated case-studies
to help you smoothen your transition to continuous manufacturing with minimal troubleshooting and maximized efficiency through advanced process modeling for tech transfer, automated lab scale processing, and bridging phase studies
2.
A unique
poster opportunity
for you and your team to gain feedback from 60+ of your biopharma process development peers to inspire your technical processing strategy and mitigate risks
3.
from the likes of Vertex, Sanofi, MIT, Takeda, Eli Lilly & Co., and others, uncovering continuous processing for small molecule, biologics, and ATMPs to help achieve greener, cost-effective production for your whole pipeline
4.
Strategic insights
towards making the shift to continuous and developing an internal business case to inspire your shift and minimize delays
5.
Community
A community of Process Development, CMC, and Analytical leaders to benchmark best practices and network with, including AstraZeneca, Pfizer, AbbVie, and Ring Therapeutics